Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (201-210 of 240) with videos related to

Pageof 24
Sort By:
Blood|September 10, 2024
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysisBrooj Abro, Matthew J Maurer, Thomas M Habermann, et al.
British Journal of Cancer|October 31, 2024
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphomaMatteo Villa, Geeta G Sharma, Federica Malighetti, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
The Journal of Experimental Medicine|April 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotypeTayla B Heavican-Foral, Yuping Li, Waseem Lone, et al.
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Blood|December 7, 2007
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomibRoberto Piva, Bruce Ruggeri, Michael Williams, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Pageof 24

Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
Blood|September 10, 2024
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysisBrooj Abro, Matthew J Maurer, Thomas M Habermann, et al.
British Journal of Cancer|October 31, 2024
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphomaMatteo Villa, Geeta G Sharma, Federica Malighetti, et al.
Nature Communications|December 13, 2023
Enhanced SREBP2-driven cholesterol biosynthesis by PKCλ/ι deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesisYu Muta, Juan F Linares, Anxo Martinez-Ordoñez, et al.
The Journal of Experimental Medicine|April 28, 2026
Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotypeTayla B Heavican-Foral, Yuping Li, Waseem Lone, et al.
Blood Cancer Discovery|June 24, 2026
A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell LymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Blood|December 7, 2007
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomibRoberto Piva, Bruce Ruggeri, Michael Williams, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphomaHaopeng Yang, Kotaro Arita, Kevin Bowman, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Pageof 24